Da warfarin metaboliseres via CYP2C9, bør patienter med behov for antikoagulantia have heparin med lav molekylevægt eller standardheparin.
Because warfarin is metabolised by CYP2C9, patients who require anticoagulation should receive low-molecular-weight or standard heparin.